Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06471998

Evaluation of the Benefit and Safety of Localized Tissue Hydration in the Management of Chronic Low Back Pain

Led by GCS Ramsay Santé pour l'Enseignement et la Recherche · Updated on 2025-03-27

29

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

Sponsors

G

GCS Ramsay Santé pour l'Enseignement et la Recherche

Lead Sponsor

E

Euraxi Pharma

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate the benefit of Localized Tissue Hydration associated with standard management of chronic common low back pain, in terms of improvement in the numerical verbal scale score at 6 months.

CONDITIONS

Official Title

Evaluation of the Benefit and Safety of Localized Tissue Hydration in the Management of Chronic Low Back Pain

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient 18 years of age or older
  • Chronic non-operated low-back pain lasting more than 3 months with a numerical verbal scale score of 5 or higher
  • Chronic common low back pain not requiring surgery
  • Lumbar MRI performed as part of routine care and available at inclusion
  • Women of childbearing age must use a highly effective contraceptive method
  • Affiliated with a French health insurance scheme
  • Signed informed consent form
Not Eligible

You will not qualify if you...

  • Pregnant or breastfeeding women
  • Patients currently in a work-related accident
  • Patients with radicular syndrome
  • Contraindications to MRI or CT scan
  • Severe fluid overload or retention conditions including decompensated heart failure, acute renal failure with low urine output, decompensated liver failure, pre-eclampsia or eclampsia
  • Hypochloremia
  • Hypernatremia
  • Adults under legal protection, guardianship, or deprived of liberty by judicial or administrative decision
  • Hospitalized patients without consent
  • Patients unable to answer questionnaires
  • Patients who do not understand or speak French
  • Participation in another interventional study within the last 8.5 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hôpital Privé Clairval

Marseille, France, 13009

Actively Recruiting

Loading map...

Research Team

P

Philippe METELLUS, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here